ÁÔÆæÖØ¿Ú

We engineer advanced biomaterials and medical devices to address complex clinical challenges, including wound healing, tissue regeneration, and hearing protection. 

Our translational research integrates material science, drug delivery, and physiologically relevant in vitro modeling to develop high-impact therapeutic solutions. 

We develop novel strategies to treat malignancies through pathway targeting, immunotherapy, and natural product discovery. 

Our work spans molecular oncology, immuno-oncology, and bioactive compound discovery. 

We develop immersive educational technologies to prepare culturally responsive healthcare professionals. 

Through partnerships with Indigenous communities and the use of virtual and extended reality platforms, we enhance empathy, cultural understanding, and clinical decision-making. 

We investigate how environmental exposures—including air pollution, wildfire smoke, nanoparticles, and asbestos—shape immune function and contribute to chronic disease. 

Our research integrates toxicology, epigenetics, neuroscience, immunology, and omics technologies to understand how pollutants affect the lung, brain, and systemic health across the lifespan. 

Our researchers define the cellular and molecular pathways that drive chronic inflammation and immune-mediated disease. 

Through studies of asthma, damage-associated molecular patterns (DAMPs), and regulatory immune pathways, we aim to develop targeted therapies that restore immune balance. 

Our department houses strong expertise in structure-guided drug design, receptor biology, kinase signaling pathways, and rational therapeutic development. 

By integrating structural biology, computational modeling, medicinal chemistry, and functional genomics, we translate molecular insight into therapeutic innovation. 

We discover and characterize bioactive compounds from medicinal plants and microbes, including organisms from extreme or symbiotic environments. 

Through bioassay-guided isolation and mechanistic studies, we identify new antimicrobial, anti-inflammatory, and anticancer agents. 

We explore the molecular foundations of brain function and neurodegenerative disease. 

Our faculty combine computational modeling, receptor pharmacology, medicinal chemistry, and environmental neuroscience to develop new approaches for treating pain, neurodegeneration, and neurologic disorders. 

We are committed to advancing equitable precision medicine, particularly in rural and Tribal communities. 

Our research examines how genetics, environment, and lifestyle factors influence drug response, with the goal of translating pharmacogenomic discoveries into accessible healthcare solutions. 

We are advancing next-generation vaccines and immune-based therapies that are safer, more precise, and more effective. 

Our faculty design novel antigen delivery systems, engineer adjuvants, and define immune mechanisms that drive durable protection against infectious diseases, cancer, and immune-mediated disorders.